DEA Approves Noramco's Big Batch of Controlled Drugs: Legal Highs Ahead?
Published Date: 1/24/2025
Notice
Summary
Noramco wants to get official approval to make large amounts of certain controlled drugs. This means they’ll be able to produce these substances legally and help supply important medicines. If approved, this could affect drug availability and industry players, with no immediate cost changes announced.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Noramco Seeks Bulk Controlled-Drug License
Noramco has applied for registration to be a bulk manufacturer of certain controlled substances. If approved, it would be allowed to legally produce large amounts of those drugs and could help supply important medicines, which may affect drug availability and industry players. The notice states there are no immediate changes to costs announced.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in